These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15067098)

  • 1. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
    Niho S; Ohe Y; Goto K; Ohmatsu H; Matsumoto T; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Feb; 34(2):69-73. PubMed ID: 15067098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
    Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
    Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
    Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
    J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor.
    Papadimitris C; Dimopoulos MA; Kostis E; Papadimitriou C; Anagnostopoulos A; Alexopoulos G; Papamichael C; Gika D; Mitsibounas D; Stamatelopoulos S
    Oncology; 1999; 57(2):127-30. PubMed ID: 10461059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
    Sipsas NV; Kosmas C; Ziakas PD; Karabelis A; Vadiaka M; Skopelitis E; Kordossis T; Tsavaris N
    Scand J Infect Dis; 2007; 39(9):786-91. PubMed ID: 17701717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with oral antibiotics of febrile neutropenia in onco-haematology. The experience of the EORTC antimicrobial group].
    Cometta A; Kern W;
    Presse Med; 2004 Mar; 33(5):327-9. PubMed ID: 15041884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
    Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
    Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
    Velasco E; Costa MA; Martins CA; Nucci M
    Am J Clin Oncol; 1995 Oct; 18(5):429-35. PubMed ID: 7572762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Kern WV; Cometta A; De Bock R; Langenaeken J; Paesmans M; Gaya H
    N Engl J Med; 1999 Jul; 341(5):312-8. PubMed ID: 10423465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
    Rubenstein EB; Rolston K; Benjamin RS; Loewy J; Escalante C; Manzullo E; Hughes P; Moreland B; Fender A; Kennedy K
    Cancer; 1993 Jun; 71(11):3640-6. PubMed ID: 8490912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
    Lalami Y; Paesmans M; Aoun M; Munoz-Bermeo R; Reuss K; Cherifi S; Alexopoulos CG; Klastersky J
    Support Care Cancer; 2004 Oct; 12(10):725-30. PubMed ID: 15235901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
    Johnson PR; Liu Yin JA; Tooth JA
    J Antimicrob Chemother; 1992 Aug; 30(2):203-14. PubMed ID: 1399929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.